Christopher Reading - Dec 2, 2022 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: Chief Executive Officer, Director
Signature: /s/ Christopher J Reading
Stock symbol: USPH
Transactions as of: Dec 2, 2022
Transactions value $: -$900,100
Form type: 4
Date filed: 12/5/2022, 02:28 PM
Previous filing: Mar 15, 2022
Next filing: Dec 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common stock	Sale	-$900K	-10K	-11.16%	$90.01	79.6K	Dec 2, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price $90.01. The shares were sold in multiple transactions at prices ranging from $90.00 to $90.44 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 28,333 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 4,129 shares on January 1, 2023; 2,848 shares on each of April 1, July 1 and October 1, 2023; 2,860 shares on January 1, 2024; 1,950 shares on each of April 1, July 1 and October 1, 2024, and on January 1, 2025; and 1,250 shares on each of April 1, July 1 and October 1, 2025, and on January 1, 2026, if he is an employee of the Company on those dates.

Content

The price reported is a weighted average price $90.01. The shares were sold in multiple transactions at prices ranging from $90.00 to $90.44 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Includes 28,333 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 4,129 shares on January 1, 2023; 2,848 shares on each of April 1, July 1 and October 1, 2023; 2,860 shares on January 1, 2024; 1,950 shares on each of April 1, July 1 and October 1, 2024, and on January 1, 2025; and 1,250 shares on each of April 1, July 1 and October 1, 2025, and on January 1, 2026, if he is an employee of the Company on those dates.